-
1
-
-
49749221179
-
Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood
-
Reye RD, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood. Lancet 1963; 91: 749-52.
-
(1963)
Lancet
, vol.91
, pp. 749-752
-
-
Reye, R.D.1
Morgan, G.2
Baral, J.3
-
2
-
-
49749183929
-
Acute meningo-encephalomyelitis of childhood: Report of 6 cases
-
Brain WR, Hunter D, Turnbull HM. Acute meningo-encephalomyelitis of childhood: report of 6 cases. Lancet 1929; 1: 221-27.
-
(1929)
Lancet
, vol.1
, pp. 221-227
-
-
Brain, W.R.1
Hunter, D.2
Turnbull, H.M.3
-
3
-
-
0025371957
-
Trends in the incidence of Reye's syndrome and the use of aspirin
-
Porter JD, Robinson PH, Glasgow JF, Banks JH, Hall SM. Trends in the incidence of Reye's syndrome and the use of aspirin. Arch Dis Child 1990; 65(8): 826-29.
-
(1990)
Arch Dis Child
, vol.65
, Issue.8
, pp. 826-829
-
-
Porter, J.D.1
Robinson, P.H.2
Glasgow, J.F.3
Banks, J.H.4
Hall, S.M.5
-
4
-
-
0033529015
-
Reye's syndrome in the United States from 1981 through 1997
-
Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999; 340(18): 1377-82.
-
(1999)
N Engl J Med
, vol.340
, Issue.18
, pp. 1377-1382
-
-
Belay, E.D.1
Bresee, J.S.2
Holman, R.C.3
Khan, A.S.4
Shahriari, A.5
Schonberger, L.B.6
-
5
-
-
0026674529
-
Reduction of deaths after drug labelling for risk of Reye's syndrome
-
Davis DL, Buffler P. Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet 1992; 340 (8826): 1042.
-
(1992)
Lancet
, vol.340
, Issue.8826
, pp. 1042
-
-
Davis, D.L.1
Buffler, P.2
-
6
-
-
0021946219
-
Pathophysiology of ammonia intoxication
-
Raabe W, Lin S. Pathophysiology of ammonia intoxication. Exp Neurol 1985; 87(3): 519-32.
-
(1985)
Exp Neurol
, vol.87
, Issue.3
, pp. 519-532
-
-
Raabe, W.1
Lin, S.2
-
7
-
-
0019733105
-
The Diagnosis and Treatment of Reye's Syndrome. NIH Consens Statement
-
The Diagnosis and Treatment of Reye's Syndrome. NIH Consens Statement. Natl Inst Health Consens Dev Conf Summ 1981; 4(1):1-15.
-
(1981)
Natl Inst Health Consens Dev Conf Summ
, vol.4
, Issue.1
, pp. 1-15
-
-
-
8
-
-
0017744177
-
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial
-
Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72(4 Pt 1): 573-83.
-
(1977)
Gastroenterology
, vol.72
, Issue.4 PART 1
, pp. 573-583
-
-
Conn, H.O.1
Leevy, C.M.2
Vlahcevic, Z.R.3
-
9
-
-
0036191173
-
-
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35(3): 716-21.
-
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35(3): 716-21.
-
-
-
-
10
-
-
77049187119
-
Rapid determination of salicylate in biological fluids
-
Trinder P. Rapid determination of salicylate in biological fluids. Biochem J 1954; 57(2): 301-03.
-
(1954)
Biochem J
, vol.57
, Issue.2
, pp. 301-303
-
-
Trinder, P.1
-
11
-
-
53349119055
-
-
y validación de aspirina (ASA) y derivados en orina
-
Cruz MF. Dosificación y validación de aspirina (ASA) y derivados en orina. Rev Cubana Pediatr 1996; 68(3): 177-82.
-
(1996)
Rev Cubana Pediatr
, vol.68
, Issue.3
, pp. 177-182
-
-
Dosificación, C.M.F.1
-
12
-
-
0020378963
-
Idiopathic acute fatty liver of pregnancy in 12 patients
-
Burroughs AK, Seong NH, Dojcinov DM, Scheuer PJ, Sherlock SV. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982; 51(204): 481-97.
-
(1982)
Q J Med
, vol.51
, Issue.204
, pp. 481-497
-
-
Burroughs, A.K.1
Seong, N.H.2
Dojcinov, D.M.3
Scheuer, P.J.4
Sherlock, S.V.5
-
13
-
-
0029098629
-
Reye's and Reye-like syndromes, drug-related diseases? (causative agents, etiology, pathogenesis, and therapeutic approaches)
-
Visentin M, Salmona M, Tacconi MT. Reye's and Reye-like syndromes, drug-related diseases? (causative agents, etiology, pathogenesis, and therapeutic approaches). Drug Metab Rev 1995; 27(3): 517-39.
-
(1995)
Drug Metab Rev
, vol.27
, Issue.3
, pp. 517-539
-
-
Visentin, M.1
Salmona, M.2
Tacconi, M.T.3
-
14
-
-
0036514204
-
Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons
-
Prandota J. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther 2002; 9(2): 149-56.
-
(2002)
Am J Ther
, vol.9
, Issue.2
, pp. 149-156
-
-
Prandota, J.1
-
15
-
-
0024462557
-
Reye's syndrome
-
Hurwitz ES. Reye's syndrome. Epidemiol Rev 1989; 11: 249-53.
-
(1989)
Epidemiol Rev
, vol.11
, pp. 249-253
-
-
Hurwitz, E.S.1
-
17
-
-
0026341780
-
Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome
-
Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259(2): 894-04.
-
(1991)
J Pharmacol Exp Ther
, vol.259
, Issue.2
, pp. 894-904
-
-
Deschamps, D.1
Fisch, C.2
Fromenty, B.3
Berson, A.4
Degott, C.5
Pessayre, D.6
-
18
-
-
84995106724
-
The effects of salicylate on ketogenesis, gluconeogenesis and urea production in rat liver perfusion
-
Terada N, Kizaki Z, Inoue F, et al. The effects of salicylate on ketogenesis, gluconeogenesis and urea production in rat liver perfusion. Acta Paediatr Jpn 1990; 32(4): 456-61.
-
(1990)
Acta Paediatr Jpn
, vol.32
, Issue.4
, pp. 456-461
-
-
Terada, N.1
Kizaki, Z.2
Inoue, F.3
-
19
-
-
26644432066
-
Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria
-
Battaglia V, Salvi M, Toninello A. Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. J Biol Chem 2005; 280(40): 33864-872.
-
(2005)
J Biol Chem
, vol.280
, Issue.40
, pp. 33864-33872
-
-
Battaglia, V.1
Salvi, M.2
Toninello, A.3
-
20
-
-
0033619660
-
Hepatic encephalopathy: Molecular mechanisms underlying the clinical syndrome
-
Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999; 170(2): 138-46.
-
(1999)
J Neurol Sci
, vol.170
, Issue.2
, pp. 138-146
-
-
Albrecht, J.1
Jones, E.A.2
-
21
-
-
0023284378
-
Ammonia: Key factor in the pathogenesis of hepatic encephalopathy
-
Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6(1-2): 1-12.
-
(1987)
Neurochem Pathol
, vol.6
, Issue.1-2
, pp. 1-12
-
-
Butterworth, R.F.1
Giguere, J.F.2
Michaud, J.3
Lavoie, J.4
Layrargues, G.P.5
-
22
-
-
0036096430
-
Glutamate transporters in hyperammonemia
-
Butterworth RF. Glutamate transporters in hyperammonemia. Neurochem Int 2002; 41(2-3): 81-85.
-
(2002)
Neurochem Int
, vol.41
, Issue.2-3
, pp. 81-85
-
-
Butterworth, R.F.1
-
23
-
-
33645851362
-
Glutamine in the mechanism of ammonia-induced astrocyte swelling
-
Jayakumar AR, Rao KV, Murthy C, Norenberg MD. Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 2006; 48(6-7): 623-28.
-
(2006)
Neurochem Int
, vol.48
, Issue.6-7
, pp. 623-628
-
-
Jayakumar, A.R.1
Rao, K.V.2
Murthy, C.3
Norenberg, M.D.4
-
24
-
-
0037373041
-
Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons
-
Himi T, Ikeda M, Yasuhara T, Murota SI. Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons. J Neurosci Res 2003; 71(5):679-88.
-
(2003)
J Neurosci Res
, vol.71
, Issue.5
, pp. 679-688
-
-
Himi, T.1
Ikeda, M.2
Yasuhara, T.3
Murota, S.I.4
-
25
-
-
0029891078
-
Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures
-
Velasco I, Tapia R, Massieu L. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J Neurosci Res 1996; 44(6): 551-61.
-
(1996)
J Neurosci Res
, vol.44
, Issue.6
, pp. 551-561
-
-
Velasco, I.1
Tapia, R.2
Massieu, L.3
-
26
-
-
0346037335
-
Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity
-
Chou YC, Lin SB, Tsai LH, Tsai HI, Lin CM. Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity. Neurochem Int 2003; 43(3): 197-209.
-
(2003)
Neurochem Int
, vol.43
, Issue.3
, pp. 197-209
-
-
Chou, Y.C.1
Lin, S.B.2
Tsai, L.H.3
Tsai, H.I.4
Lin, C.M.5
-
27
-
-
4444244974
-
Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication
-
Scorticati C, Prestifilippo JP, Eizayaga FX, et al. Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication. World J Gastroenterol 2004; 10(9): 1321-24.
-
(2004)
World J Gastroenterol
, vol.10
, Issue.9
, pp. 1321-1324
-
-
Scorticati, C.1
Prestifilippo, J.P.2
Eizayaga, F.X.3
|